Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(10%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_4
1
10%
Ph not_applicable
8
80%
Ph phase_2
1
10%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
1(10.0%)
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
8(80.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(4)
Terminated(2)
Other(2)

Detailed Status

Completed4
unknown2
Withdrawn2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (10.0%)
Phase 41 (10.0%)
N/A8 (80.0%)

Trials by Status

unknown220%
completed440%
not_yet_recruiting110%
recruiting110%
withdrawn220%

Recent Activity

1 active trials
Showing 5 of 10
recruitingnot_applicable

Comparison Between Water Vapor Thermal Therapy and Prostatic Artery Embolization in Treatment of Benign Prostatic Hyperplasia

NCT07416227
not_yet_recruitingphase_2

Neoadjuvant Embolization and Cytoreduction in Prostate Cancer

NCT07251829
withdrawnnot_applicable

Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy

NCT05415696
completednot_applicable

Prostatic Artery Embolization vs. Conventional Transurethral Prostatectomy in the Treatment of Benign Prostatic Hyperplasia

NCT02054013
withdrawnnot_applicable

Prostatic Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)

NCT04563221
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07416227Not Applicable

Comparison Between Water Vapor Thermal Therapy and Prostatic Artery Embolization in Treatment of Benign Prostatic Hyperplasia

Recruiting
NCT07251829Phase 2

Neoadjuvant Embolization and Cytoreduction in Prostate Cancer

Not Yet Recruiting
NCT05415696Not Applicable

Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy

Withdrawn
NCT02054013Not Applicable

Prostatic Artery Embolization vs. Conventional Transurethral Prostatectomy in the Treatment of Benign Prostatic Hyperplasia

Completed
NCT04563221Not Applicable

Prostatic Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)

Withdrawn
NCT03372096Not Applicable

LC Bead LUMI for Prostatic Artery Embolization

Completed
NCT03457805Not Applicable

Prostatic Artery Embolization in Advanced Prostate Cancer

Unknown
NCT03099421Not Applicable

Prostatic Artery Embolization for Benign Prostatic Obstruction

Completed
NCT03104907Not Applicable

Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer

Completed
NCT02006303Phase 4

Prostatic Artery Embolization Versus 532 nm Green Light PVP for Catheterized Patients

Unknown

All 10 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
10